Horton J - Search Results

1

Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group.

Wiernik PH, Yeap B, Vogl SE, Kaplan BH, Comis RL, Falkson G, Davis TE, Fazzini E, Cheuvart B, Horton J. Wiernik PH, et al. Among authors: horton j. Cancer Invest. 1992;10(1):1-9. doi: 10.3109/07357909209032783. Cancer Invest. 1992. PMID: 1735009 Clinical Trial.

2

Methotrexate alone or with regional subcutaneous Corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neck.

Vogl SE, Schoenfeld DA, Kaplan BH, Lerner HJ, Horton J, Creech RH, Barnes LE. Vogl SE, et al. Among authors: horton j. Cancer. 1982 Dec 1;50(11):2295-300. doi: 10.1002/1097-0142(19821201)50:11<2295::aid-cncr2820501113>3.0.co;2-4. Cancer. 1982. PMID: 6754063 Clinical Trial.

3

Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen.

Gale KE, Andersen JW, Tormey DC, Mansour EG, Davis TE, Horton J, Wolter JM, Smith TJ, Cummings FJ. Gale KE, et al. Among authors: horton j. Cancer. 1994 Jan 15;73(2):354-61. doi: 10.1002/1097-0142(19940115)73:2<354::aid-cncr2820730220>3.0.co;2-j. Cancer. 1994. PMID: 8293400 Clinical Trial.

4

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.

Vogl SE, Schoenfeld DA, Kaplan BH, Lerner HJ, Engstrom PF, Horton J. Vogl SE, et al. Among authors: horton j. Cancer. 1985 Aug 1;56(3):432-42. doi: 10.1002/1097-0142(19850801)56:3<432::aid-cncr2820560304>3.0.co;2-x. Cancer. 1985. PMID: 2408735 Clinical Trial.

5

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma.

Schoenfeld DA, Rosenbaum C, Horton J, Wolter JM, Falkson G, DeConti RC. Schoenfeld DA, et al. Among authors: horton j. Cancer. 1982 Dec 15;50(12):2757-62. doi: 10.1002/1097-0142(19821215)50:12<2757::aid-cncr2820501211>3.0.co;2-j. Cancer. 1982. PMID: 7139566

6

Phase II study of methyl-glyoxal bis-guanylhydrazone (NSC 3296) in advanced ovarian cancer.

Vogl SE, Pagano M, Horton J. Vogl SE, et al. Among authors: horton j. Am J Clin Oncol. 1984 Dec;7(6):733-6. doi: 10.1097/00000421-198412000-00025. Am J Clin Oncol. 1984. PMID: 6528867

7

Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.

Levin M, Pandya KJ, Khandekar JD, Horton J, Glick JH, Bennett JM, Muggia FM, Falkson G. Levin M, et al. Among authors: horton j. Cancer Treat Rep. 1984 Dec;68(12):1511-2. Cancer Treat Rep. 1984. PMID: 6509455 No abstract available.

8

Phase II evaluation of phenesterin in patients with advanced ovarian cancer.

Bloom RE, Polivogianis L, Davis TE, Bennett JM, Horton J. Bloom RE, et al. Among authors: horton j. Cancer Treat Rep. 1983 Jun;67(6):601-2. Cancer Treat Rep. 1983. PMID: 6861167 No abstract available.

9

Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Oken MM, et al. Among authors: horton j. Am J Clin Oncol. 1982 Dec;5(6):649-55. Am J Clin Oncol. 1982. PMID: 7165009 No abstract available.

10

Trials of single-agent and combination chemotherapy for advanced cancer of the pancreas.

Horton J, Gelber RD, Engstrom P, Falkson G, Moertel C, Brodovsky H, Douglass H. Horton J, et al. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):65-8. Cancer Treat Rep. 1981. PMID: 6452948 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,974 results

Search Page

Filters